Jane Street
LKFT

Jane Street’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jane Street’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$408K Buy
+13,607
New +$451K ﹤0.01% 8514
2025
Q4 		– Sell
-9,049
Closed -$313K – 11603
2025
Q3 		$313K Sell
9,049
-21,726
-71% -$695K ﹤0.01% 8812
2025
Q2 		$861K Sell
30,775
-80,008
-72% -$2.14M ﹤0.01% 5895
2025
Q1 		$2.78M Buy
110,783
+99,646
+895% +$2.52M ﹤0.01% 3827
2024
Q4 		$306K Buy
+11,137
New +$310K ﹤0.01% 7705
2024
Q1 		– Sell
-42,682
Closed -$1.74M – 9519
2023
Q4 		$1.74M Buy
+42,682
New +$1.57M ﹤0.01% 4585
2022
Q4 		– Sell
-66,424
Closed -$2.83M – 9477
2022
Q3 		$2.83M Sell
66,424
-73,810
-53% -$3.78M ﹤0.01% 3556
2022
Q2 		$7.83M Buy
140,234
+121,655
+655% +$7.21M ﹤0.01% 2038
2022
Q1 		$1.15M Buy
18,579
+14,860
+400% +$910K ﹤0.01% 5838
2021
Q4 		$205K Sell
3,719
-2,133
-36% -$111K ﹤0.01% 8789
2021
Q3 		$308K Sell
5,852
-6,316
-52% -$375K ﹤0.01% 8127
2021
Q2 		$838K Sell
12,168
-4,773
-28% -$364K ﹤0.01% 6217
2021
Q1 		$1.31M Sell
16,941
-27,392
-62% -$2.52M ﹤0.01% 4927
2020
Q4 		$4.39M Buy
44,333
+13,370
+43% +$1.63M ﹤0.01% 2299
2020
Q3 		$4.39M Sell
30,963
-25,996
-46% -$4.33M ﹤0.01% 1993
2020
Q2 		$11.2M Buy
56,959
+45,752
+408% +$9.48M 0.01% 1110
2020
Q1 		$2.2M Sell
11,207
-84,395
-88% -$18.2M ﹤0.01% 1931
2019
Q4 		$19.8M Buy
95,602
+36,008
+60% +$6.66M 0.03% 381
2019
Q3 		$9.1M Buy
59,594
+51,147
+606% +$8.38M 0.02% 644
2019
Q2 		$1.09M Buy
+8,447
New +$1M ﹤0.01% 2590
2019
Q1 		– Sell
-54,536
Closed -$5M – 5231
2018
Q4 		$5M Sell
54,536
-130,733
-71% -$13.3M 0.01% 952
2018
Q3 		$20.8M Buy
185,269
+126,277
+214% +$13.3M 0.04% 322
2018
Q2 		$5.44M Sell
58,992
-31,594
-35% -$3.07M 0.01% 971
2018
Q1 		$9.04M Sell
90,586
-46,626
-34% -$5.03M 0.02% 593
2017
Q4 		$12.9M Buy
137,212
+63,958
+87% +$6.05M 0.04% 418
2017
Q3 		$7.45M Sell
73,254
-45,885
-39% -$4.01M 0.02% 637
2017
Q2 		$9.12M Buy
+119,139
New +$10M 0.03% 497
2015
Q4 		– Sell
-25,984
Closed -$1.06M – 4160
2015
Q3 		$1.06M Buy
+25,984
New +$1.5M 0.01% 1586

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's LKFT Position: Q1 2026 in Review

Jane Street opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 13,607 shares worth $408K. The stake represents ﹤0.01% of the portfolio and ranks #8514 among its holdings. This is a return to the name: Jane Street previously reported a position in LKFT as recently as Q3 2025.

Jane Street first reported a position in LKFT in Q3 2015 and has held it in 28 quarters since. The position peaked at $20.8M in Q3 2018. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Jane Street held 13,607 shares of Lakefront Biotherapeutics American Depositary Shares worth $408K as of Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Jane Street position in Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8514 holding.
  • Jane Street first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 28 quarters since.
  • Jane Street's Lakefront Biotherapeutics American Depositary Shares position peaked at $20.8M in Q3 2018.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.